Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach

被引:14
作者
Benaboud, Sihem [1 ,2 ]
Urien, Saik [1 ,2 ]
Thervet, Eric [3 ]
Prie, Dominique [4 ]
Legendre, Christophe [5 ]
Souberbielle, Jean-Claude [4 ]
Hirt, Deborah [1 ,2 ,6 ]
Friedlander, Gerard [4 ]
Treluyer, Jean Marc [1 ,2 ,6 ]
Courbebaisse, Marie [4 ]
机构
[1] Univ Paris 05, EA3620, Sorbonne Paris Cite, Paris, France
[2] Hop Tarnier, AP HP, Unite Rech Clin, F-75006 Paris, France
[3] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France
[4] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France
[5] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Transplantat Renale, Paris, France
[6] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Serv Pharmacol Clin, Paris, France
关键词
25-Hydroxy vitamin D; Vitamin D insufficiency; Pharmacokinetic modeling; Optimal dosing; Kidney transplant patients; Cholecalciferol; VITAMIN-D SUPPLEMENTATION; EXPRESSION; CLEARANCE; CANCER;
D O I
10.1007/s00228-012-1378-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose No information on optimal cholecalciferol dosing in kidney transplant patients is currently available because the time-course of serum 25-hydroxy vitamin D [25(OH)D] concentration has never been investigated. The aim of this study was to investigate 25(OH)D pharmacokinetics in renal transplant recipients and to determine the optimal dosage scheme allowing 25(OH)D concentrations to be maintained between 30-80 ng/mL during the first year post-transplantation. Methods Four months after renal transplantation, 49 patients received four oral doses of 100,000 IU cholecalciferol every 2 weeks (intensive phase), then every 2 months until 1 year after transplantation (maintenance phase). A control group of 47 transplanted patients was not supplemented but underwent blood sampling. In the treated group, 74 samples were collected before the first cholecalciferol administration and 119 thereafter. Two blood samples per patient were collected in the control group. Serum 25(OH)D concentrations were analyzed using a population approach. The turnover of 25(OH)D was modeled using a one-compartment-model with first-order formation and elimination and basal concentration. Results The mean population parameter estimates and the associated between-subject variability were: formation rate constant (k(f)), 0.11 day(-1); clearance (CL/F), 2.5 L/day (0.42); central volume of distribution (V-C/F), 237 L; basal concentration (C-0), 12.82 ng/mL (0.41). Based on these values, in order to maintain 25(OH)D concentrations between 30 and 80 ng/mL, cholecalciferol dosing should be six successive administrations of 100,000 IU at 2-week intervals, followed by 100,000 IU once a month until the end of the first year. Conclusions We present here the first pharmacokinetic model describing the time-course of 25(OH)D. We propose an optimal and practical scheme for the treatment of vitamin D insufficiency after renal transplantation. Taking into account the numerous effects of vitamin D on health, this scheme could help clinicians improve the care of kidney recipients.
引用
收藏
页码:499 / 506
页数:8
相关论文
共 20 条
[1]   Regulation of vitamin D-1α-hydroxylase and-24-hydroxylase expression by dexamethasone in mouse kidney [J].
Akeno, N ;
Matsunuma, A ;
Maeda, T ;
Kawane, T ;
Horiuchi, N .
JOURNAL OF ENDOCRINOLOGY, 2000, 164 (03) :339-348
[2]  
BATCHELOR AJ, 1982, GUT, V23, P1068, DOI 10.1136/gut.23.12.1068
[3]   Post-transplant hypophosphatemia:: Tertiary 'hyper-phosphatoninism'? [J].
Bhan, I. ;
Shah, A. ;
Holmes, J. ;
Isakova, T. ;
Gutierrez, O. ;
Burnett, S-A ;
Jueppner, H. ;
Wolf, M. .
KIDNEY INTERNATIONAL, 2006, 70 (08) :1486-1494
[4]   THE ROLE OF 1,25-DIHYDROXYVITAMIN-D IN THE MECHANISM OF ACQUIRED VITAMIN-D DEFICIENCY [J].
CLEMENTS, MR ;
DAVIES, M ;
HAYES, ME ;
HICKEY, CD ;
LUMB, GA ;
MAWER, EB ;
ADAMS, PH .
CLINICAL ENDOCRINOLOGY, 1992, 37 (01) :17-27
[5]   Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models:: The npde add-on package for R [J].
Comets, Emmanuelle ;
Brendel, Karl ;
Mentre, France .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2008, 90 (02) :154-166
[6]   Potential Nonclassical Effects of Vitamin D in Transplant Recipients [J].
Courbebaisse, Marie ;
Souberbielle, Jean-Claude ;
Thervet, Eric .
TRANSPLANTATION, 2010, 89 (02) :131-137
[7]   Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients [J].
Courbebaisse, Marie ;
Thervet, Eric ;
Souberbielle, Jean Claude ;
Zuber, Julien ;
Eladari, Dominique ;
Martinez, Frank ;
Mamzer-Bruneel, Marie-France ;
Urena, Pablo ;
Legendre, Christophe ;
Friedlander, Gerard ;
Prie, Dominique .
KIDNEY INTERNATIONAL, 2009, 75 (06) :646-651
[8]  
GASPARI F, 1995, J AM SOC NEPHROL, V6, P257
[9]   Vitamin D deficiency [J].
Holick, Michael F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03) :266-281
[10]  
Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI [10.1210/jc.2011-0385, 10.1210/jc.2011-1193]